Drug intelligence / Profile preview

NLH-001

Development stage: Unknown
Lead developer: Hanwha Pharma
Administration: Oral

Overview

NLH-001 is a health functional food (nutraceutical) developed and launched by Han Wha Pharma. It is positioned within the company's pipeline as a product with antioxidant and skin-whitening properties. As a health functional food in the South Korean market, it has undergone regulatory approval for these specific functional claims. The product is designed to support skin health by reducing oxidative stress and potentially inhibiting melanin production, though the specific active ingredients are not publicly detailed in the primary pipeline documentation.

Beyond the preview

Go deeper on NLH-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLH-001.

Explore the full profile